The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Pohl, R. B.
* Articles by Clary, C. M.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Pohl, R. B.
* Articles by Clary, C. M.
Related Collections
* Panic Disorder
* Antidepressants
Am J Psychiatry 155:1189-1195, September 1998
©Copyright 1998 American Psychiatric Association


Regular Article

Sertraline in the Treatment of Panic Disorder: A Double-Blind Multicenter Trial

Robert B. Pohl, M.D, Robert M. Wolkow, M.D., and Cathryn M. Clary, M.D.

Objective: This study determined the efficacy and safety of sertraline in the treatment of patients with panic disorder. Method: The study was a randomized, double-blind, parallel-group, flexible-dose comparison of sertraline and placebo in outpatients with a DSM-III-R diagnosis of panic disorder with or without agoraphobia. After a 2-week single-blind placebo lead-in, 168 patients entered a 10-week double-blind phase in which they were randomly assigned to treatment with either sertraline or placebo.Results: Sertraline was significantly more effective than placebo in decreasing the number of full and limited-symptom panic attacks. Among patients who completed the study, the mean number of panic attacks per week dropped by 88% in the sertraline-treated patients and 53% in the placebo-treated patients. Sertraline-treated patients also had significantly more improvement than placebo-treated patients in scores on the Quality of Life Enjoyment and Satisfaction Questionnaire, patient global evaluation, and Clinical Global Impression severity of illness and global improvement scales. Overall, patients tolerated sertraline well, and only 9% terminated treatment because of side effects.Conclusions: Sertraline is an effective and well-tolerated treatment for patients with panic disorder. Am J Psychiatry 1998; 155: 1189-1195




This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
C. Allgulander, A. A. Dahl, C. Austin, P. L.P. Morris, J. A. Sogaard, R. Fayyad, S. P. Kutcher, and C. M. Clary
Efficacy of Sertraline in a 12-Week Trial for Generalized Anxiety Disorder
Am J Psychiatry, September 1, 2004; 161(9): 1642 - 1649.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
J. P. Staab, M. J. Ruckenstein, D. Solomon, and N. T. Shepard
Serotonin Reuptake Inhibitors for Dizziness With Psychiatric Symptoms
Arch Otolaryngol Head Neck Surg, May 1, 2002; 128(5): 554 - 560.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
M. W. Otto, K. S. Tuby, R. A. Gould, R. Y.S. McLean, and M. H. Pollack
An Effect-Size Analysis of the Relative Efficacy and Tolerability of Serotonin Selective Reuptake Inhibitors for Panic Disorder
Am J Psychiatry, December 1, 2001; 158(12): 1989 - 1992.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
D. MICHELSON, C. ALLGULANDER, K. DANTENDORFER, A. KNEZEVIC, D. MAIERHOFER, V. MICEV, V. R. PAUNOVIC, I. TIMOTIJEVIC, N. SARKAR, L. SKOGLUND, et al.
Efficacy of usual antidepressant dosing regimens of fluoxetine in panic disorder: Randomised, placebo-controlled trial
The British Journal of Psychiatry, December 1, 2001; 179(6): 514 - 518.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. M. Gorman
A 28-Year-Old Woman With Panic Disorder
JAMA, July 25, 2001; 286(4): 450 - 457.
[Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
A. W. Goddard, T. Brouette, A. Almai, P. Jetty, S. W. Woods, and D. Charney
Early Coadministration of Clonazepam With Sertraline for Panic Disorder
Arch Gen Psychiatry, July 1, 2001; 58(7): 681 - 686.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
J. R. T. Davidson, B. O. Rothbaum, B. A. van der Kolk, C. R. Sikes, and G. M. Farfel
Multicenter, Double-blind Comparison of Sertraline and Placebo in the Treatment of Posttraumatic Stress Disorder
Arch Gen Psychiatry, May 1, 2001; 58(5): 485 - 492.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
K. Brady, T. Pearlstein, G. M. Asnis, D. Baker, B. Rothbaum, C. R. Sikes, and G. M. Farfel
Efficacy and Safety of Sertraline Treatment of Posttraumatic Stress Disorder: A Randomized Controlled Trial
JAMA, April 12, 2000; 283(14): 1837 - 1844.
[Abstract] [Full Text] [PDF]


Home page
JWatch Women's HealthHome page
Sertraline Effective in Panic Disorder
Journal Watch Women's Health, October 1, 1998; 1998(1001): 23 - 23.
[Full Text]




Get information about faster international access.

Privacy Policy

Copyright © 1998 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org